762 related articles for article (PubMed ID: 32281317)
1. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY
J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317
[TBL] [Abstract][Full Text] [Related]
2. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
3. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
4. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
Zeng QL; Yu ZJ; Gou JJ; Li GM; Ma SH; Zhang GF; Xu JH; Lin WB; Cui GL; Zhang MM; Li C; Wang ZS; Zhang ZH; Liu ZS
J Infect Dis; 2020 Jun; 222(1):38-43. PubMed ID: 32348485
[TBL] [Abstract][Full Text] [Related]
5. Why should we use convalescent plasma for COVID-19?
Franchini M
Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
[No Abstract] [Full Text] [Related]
6. Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience.
Subbarao K; Mordant F; Rudraraju R
Eur J Immunol; 2020 Oct; 50(10):1447-1453. PubMed ID: 32886952
[TBL] [Abstract][Full Text] [Related]
7. Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2).
Maveddat A; Mallah H; Rao S; Ali K; Sherali S; Nugent K
Int J Occup Environ Med; 2020 Oct; 11(4):157-178. PubMed ID: 33098401
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis.
Devasenapathy N; Ye Z; Loeb M; Fang F; Najafabadi BT; Xiao Y; Couban R; Bégin P; Guyatt G
CMAJ; 2020 Jul; 192(27):E745-E755. PubMed ID: 32444482
[TBL] [Abstract][Full Text] [Related]
9. Convalescent plasma for covid-19.
Estcourt LJ; Roberts DJ
BMJ; 2020 Sep; 370():m3516. PubMed ID: 32933945
[No Abstract] [Full Text] [Related]
10. [Use of convalescent plasma for COVID-19 treatment. History and evidence].
McAllister F; Mantegazza A; Garzón F; Rotbaum V; Remondino G; Vazquez Larsson M; Geffner J; Rabinovich GA; Bover L
Medicina (B Aires); 2020; 80 Suppl 3():82-86. PubMed ID: 32658853
[No Abstract] [Full Text] [Related]
11. Challenges of Convalescent Plasma Therapy on COVID-19.
Zhao Q; He Y
J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
[No Abstract] [Full Text] [Related]
12. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
Li L; Zhang W; Hu Y; Tong X; Zheng S; Yang J; Kong Y; Ren L; Wei Q; Mei H; Hu C; Tao C; Yang R; Wang J; Yu Y; Guo Y; Wu X; Xu Z; Zeng L; Xiong N; Chen L; Wang J; Man N; Liu Y; Xu H; Deng E; Zhang X; Li C; Wang C; Su S; Zhang L; Wang J; Wu Y; Liu Z
JAMA; 2020 Aug; 324(5):460-470. PubMed ID: 32492084
[TBL] [Abstract][Full Text] [Related]
13. Convalescent Plasma and COVID-19.
Malani AN; Sherbeck JP; Malani PN
JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
[No Abstract] [Full Text] [Related]
14. The resurgence of convalescent plasma therapy.
The Lancet Haematology
Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
[No Abstract] [Full Text] [Related]
15. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
Prajapati S
Homeopathy; 2020 Aug; 109(3):184-185. PubMed ID: 32645727
[No Abstract] [Full Text] [Related]
16. Convalescent Plasma: Promise for COVID-19 Pandemic.
Sheikh S; Baig MA
J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
[No Abstract] [Full Text] [Related]
17. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
18. Convalescent plasma is ineffective for covid-19.
Pathak EB
BMJ; 2020 Oct; 371():m4072. PubMed ID: 33093025
[No Abstract] [Full Text] [Related]
19. Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients.
Tremblay D; Seah C; Schneider T; Bhalla S; Feld J; Naymagon L; Wang B; Patel V; Jun T; Jandl T; Rahman F; Liu STH; Aberg JA; Bouvier N;
Cancer Med; 2020 Nov; 9(22):8571-8578. PubMed ID: 32945149
[TBL] [Abstract][Full Text] [Related]
20. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
